M. Nakazono et al.
Journal of Photochemistry & Photobiology, A: Chemistry 403 (2020) 112851
under optimum CL conditions. During the course of these studies it was
revealed that 4-(Methoxycarbonyl)phenyl 10-methyl-10λ4-2,7-dime-
thylacridine-9-carboxylate gave relatively strong CL intensities at pH
7ꢀ 10. To gain further insights into the influence of the different sub-
stituents, the charge on the carbon at the 9-position on the acridine
moiety was calculated. The relationships between reaction time and
reaction products on the CL of the acridinium ester were investigated.
Hz, 2 H), 8.84 (d, J =10 Hz, 2 H). 13C NMR (125.7 MHz, DMSO-d6)
125.3, 129.1, 137.5, 140, 153.6, 159.4, 163.7, 165.9. HRFAB-MS (m/z)
calculated for C25H22NO6 [M]+ 432.1447, found 432.1449. Anal Calcd
for C26H22F3NO9S: C, 53.70; H, 3.81; N, 2.41 Found: C, 53.52; H, 3.81;
N, 2.34.
2.3.3. 4-(Methoxycarbonyl)phenyl 10-methyl-10λ4-2,7-dibromoacridine-
9-carboxylate, trifluoromethanesulfonate salt (4a)
2. Experimental
Yellow solid (10 mg, 14 % yield), m.p. 262ꢀ 265 ◦C. 1H NMR (500
MHz, Chloroform-d) 3.99 (s, 3 H), 5.17 (s, 3 H), 7.57 (d, J =9 Hz, 2 H),
8.28 (d, J =8.5 Hz, 2 H), 8.5 (m, 4 H), 8.76 (d, J =9.5 Hz, 2 H). 13C NMR
(125.7 MHz, DMSO-d6) 72.7, 112.5, 125.8, 128, 139.1, 154.2, 165.8,
169.8. HRFAB-MS (m/z) calculated for C23H16Br2NO4 [M]+ 527.9446,
found 527.9450. Anal Calcd for C24H16Br2F3NO7S: C, 42.44; H, 2.37; N,
2.06 Found: C, 42.15; H, 2.34; N, 1.99.
2.1. Chemicals
All reagents were obtained commercially and were used as received
without further purification. Compounds 1a, 1b, and PMAC were pre-
pared by a previously reported method [13]. 2,7,10-Trimethyl-9(10
H)-acridone was also synthesized as reported previously [16].
2.3.4. 4-(Methoxycarbonyl)phenyl 10-methyl-10λ4-2,7-diphenylacridine-
9-carboxylate, trifluoromethanesulfonate salt (5a)
2.2. Apparatus
Red solid (27 mg, 12 % yield), m.p. 254ꢀ 257 ◦C. 1H NMR (600 MHz,
Acetone-d6) 3.95 (s, 3 H), 5.36 (s, 3 H), 7.6 (m, 2 H), 7.64 (m, 4 H), 7.89
(d, J =8.4 Hz, 2 H), 8.03 (m, 4 H), 8.26 (dd, J = 1.8, 6.6 Hz, 2 H), 8.84 (s,
2 H), 8.99 (dd, J = 1.8, 9.6 Hz, 2 H), 9.2 (d, J =9.6 Hz, 2 H). 13C NMR
(150.9 MHz, DMSO-d6) 40.7, 52.9, 114.3, 121.4, 121.8, 122.7, 123.4,
124, 125.2, 126.4, 127.3, 127.9, 128.2, 129, 129.5, 130, 131.4, 131.8,
132.3, 137.1, 138.7, 140, 141.1, 141.7, 145.3, 153.7, 162.9, 165.8, 171.
HRFAB-MS (m/z) calculated for C35H26NO4 [M]+ 524.1862, found
524.1890. Anal Calcd for C36H26F3NO7S: C, 64.19; H, 3.89; N, 2.08
Found: C, 62.08; H, 3.98; N, 1.94.
The melting points were uncorrected. The 1H-NMR spectra were
recorded on 500 and 600 MHz spectrometers. The 13C-NMR spectra
were recorded on 125.7 and 150.9 MHz spectrometers. HRMS spectra
were obtained by fast atom bombardment. Chemiluminescence was
measured using a Lumat LB 9507 (Berthold, Bad Wildbad, Germany)
luminometer. The fluorescence and CL spectra were obtained using a FP-
6500 fluorometer (JASCO, Tokyo, Japan). A conventional reversed-
phase HPLC system was conducted using a JASCO (Tokyo, Japan) PU-
980 pump, a UV-970 detector, and a CAPCELL PAK C18 (5 μm, 250
mm x 4.6 mm i.d.) column. The HPLC conditions were as follows: mobile
phase, 75 % acetonitrile-H2O; flow rate, 0.83 mL/min; detection
wavelength, 280 nm.
2.3.5. 3,4-(Dimethoxycarbonyl)phenyl 10-methyl-10λ4-2,7-
dimethylacridine-9-carboxylate, trifluoromethanesulfonate salt (2b)
Yellow solid (0.20 g, 62 % yield), m.p. 274ꢀ 277 ◦C. 1H NMR (600
MHz, DMSO-d6) 2.74 (s, 6 H), 3.9 (s, 3 H), 3.91 (s, 3 H), 4.93 (s, 3 H),
8.05 (m, 2 H), 8.19 (d, J =2.4 Hz, 1 H), 8.34 (s, 2 H), 8.37 (dd, J = 1.8,
9.6 Hz, 2 H), 8.83 (d, J =9 Hz, 2 H). 13C NMR (150.9 MHz, DMSO-d6)
21.4, 53.4, 53.5, 120.1, 122.8, 123.1, 125.2, 125.4, 130, 131.5, 134.6,
140.6, 140.9, 141.6, 143.8 151.8, 163.3, 166.6, 167.1. HRFAB-MS (m/z)
calculated for C27H24NO6 [M]+ 458.1604, found 458.1605. Anal Calcd
for C28H24F3NO9S: C, 55.35; H, 3.98; N, 2.31 Found: C, 54.68; H, 3.96;
N, 2.25.
2.3. General procedure for the synthesis of 2aꢀ 5a and 2bꢀ 5b (Scheme
1)
To a solution of acridine-9-carbonyl chloride (0.1 g, 0.33 mmol) in
dry dichloromethane (5 mL) under nitrogen gas was added 4-dimethyla-
minopyridine (0.02 g, 0.16 mmol), the corresponding phenols (0.66
mmol), and triethylamine (0.4 mL). The mixture was stirred at ambient
temperature overnight. Chloroform (100 mL) and aqueous 10 % (w/v)
sodium chloride (100 mL) were added to the solution. The organic layer
was dried with anhydrous sodium sulfate. The filtrate was evaporated in
vacuo, and the residue was purified by column chromatography (silica
2.3.6. 3,4-(Dimethoxycarbonyl)phenyl 10-methyl-10λ4-2,7-
dimethoxyacridine-9-carboxylate, trifluoromethanesulfonate salt (3b)
Yellow solid (0.01 g, 4% yield), m.p. 228ꢀ 230 ◦C. 1H NMR (500
MHz, DMSO-d6) 3.87 (s, 6 H), 4.11 (s, 6 H), 4.93 (s, 3 H), 7.59 (d, J =3
Hz, 2 H), 8.02 (m, 2 H), 8.12 (m, 3 H), 8.83 (d, J =10.5 Hz, 2 H). 13C
NMR (125.7 MHz, DMSO-d6) 125.4, 130.3, 134.4, 137.5, 139.6, 151.9,
159.4, 163.5, 166.8, 166.9. HRFAB-MS (m/z) calculated for C27H24NO8
[M]+ 490.1502, found 490.1503. Anal Calcd for C28H24F3NO11S: C,
52.58; H, 3.78; N, 2.19 Found: C, 51.41; H, 3.89; N, 2.08.
gel, 40ꢀ 50 μm, chloroform-methanol or ethyl acetate-hexane solution)
to produce the desired acridine-9-carboxylates. The acridine-9-
carboxylates were N-methylated by methyl trifluoromethanesulfonate
in dichloromethane and were purified by column chromatography (sil-
ica gel, particle size 40ꢀ 50 μm, chloroform-methanol) to produce the
desired acridine-9-carboxylates, trifluoromethanesulfonate salt ().
2.3.1. 4-(Methoxycarbonyl)phenyl 10-methyl-10λ4-2,7-dimethylacridine-
9-carboxylate, trifluoromethanesulfonate salt (2a)
2.3.7. 3,4-(Dimethoxycarbonyl)phenyl 10-methyl-10λ4-2,7-
Yellow solid (0.17 g, 65 % yield), m.p. 284ꢀ 287 ◦C. 1H NMR (600
MHz, DMSO-d6) 2.75 (s, 6 H), 3.93 (s, 3 H), 4.93 (s, 3 H), 7.94 (m, 2 H),
8.21 (m, 2 H), 8.3 (s, 2 H), 8.37 (m, 2 H), 8.84 (d, J =8 Hz, 2 H). 13C NMR
(150.9 MHz, DMSO-d6) 21.4, 52.9, 120.1, 123, 123.1, 125.1, 129.1,
131.6, 140.6, 140.9, 141.6, 144.1, 153.4, 163.5, 165.8. HRFAB-MS (m/
z) calculated for C25H22NO4 [M]+ 400.1549, found 400.1549. Anal
Calcd for C26H22F3NO7S: C, 56.83; H, 4.04; N, 2.55 Found: C, 55.83; H,
4.04; N, 2.48.
dibromoacridine-9-carboxylate, trifluoromethanesulfonate salt (4b)
Yellow solid (50 mg, 14 % yield), m.p. 242ꢀ 245 ◦C. 1H NMR (500
MHz, DMSO-d6) 3.44 (s, 3 H), 3.78 (s, 6 H), 7.13 (m, 4 H), 7.54 (dd, J =
2.5, 9 Hz, 2 H), 7.75 (d, J =8 Hz, 1 H), 7.81 (d, J =2.5 Hz, 2 H). 13C NMR
(125.7 MHz, DMSO-d6) 72.7, 112.5, 125.7, 129.2, 134.1, 139.2, 152.5,
166.7, 166.8, 169.8. HRFAB-MS (m/z) calculated for C25H18Br2NO6
[M]+ 585.9501, found 585.9527. Anal Calcd for C26H18Br2F3NO9S: C,
42.36; H, 2.46; N, 1.90 Found: C, 41.47; H, 2.55; N, 1.79.
2.3.8. 3,4-(Dimethoxycarbonyl)phenyl 10-methyl-10λ4-2,7-
2.3.2. 4-(Methoxycarbonyl)phenyl 10-methyl-10λ4-2,7-
diphenylacridine-9-carboxylate, trifluoromethanesulfonate salt (5b)
Yellow solid (30 mg, 11 % yield), m.p. 250ꢀ 253 ◦C. 1H NMR (600
MHz, Acetone-d6) 3.93 (s, 6 H), 5.36 (s, 3 H), 7.6 (m, 6 H), 8.03 (m, 7 H),
8.89 (d, J =1.8 Hz, 2 H), 8.98 (dd, J = 1.8, 9.6 Hz, 2 H), 9.19 (d, J =9.6
dimethoxyacridine-9-carboxylate, trifluoromethanesulfonate salt (3a)
Orange solid (0.02 g, 9% yield), m.p. 250ꢀ 253 C. 1H NMR (500
◦
MHz, DMSO-d6) 3.91 (s, 3 H), 4.12 (s, 6 H), 4.93 (s, 3 H), 7.54 (d, J =3
Hz, 2 H), 7.86 (d, J =9 Hz, 2 H), 8.12 (dd, J = 3, 10 Hz, 2 H), 8.2 (d, J =9
3